Small Cap Traders Delivers Brief Report: IntelGenx Technologies Corporation Targeting Better Outcomes
NEW YORK, Nov. 6, 2014 /PRNewswire/ -- Brief Analyst Report by Small Cap Traders. IntelGenx Technologies Corporation (OTCBB: IGXT) – According to a January 2014 report by BCCResearch, global revenues for advanced drug delivery systems in 2013 were an estimated $151.3 billion. Revenues for advanced drug delivery systems are estimated to grow by compound annual growth rate (CAGR) of 2.8% through 2018, reaching $173.8 billion. These targeted drug delivery systems are used to increase the concentration of medications in some parts of the human body relative to other parts. This reduces the frequency of drug dosages required by the patient, results in a more uniform effect from the drug, and lowers drug side-effects. One company involved in this industry is IntelGenx Technologies Corporation.
IntelGenx Technologies Corporation is a Montreal based drug delivery company, which develops proprietary technologies for enhanced drug delivery. The company has three delivery platform technologies: the Multilayer Tablet technology for the development of oral controlled-release products; the Oral Film technology for the delivery of pharmaceuticals to the oral cavity; and the Mucoadhesive Tablet technology for controlled release of active substances to the oral mucosa. The company provides its product development services to the pharmaceutical industry, for both branded and generic pharmaceuticals.
A brief analyst report on IGXT that includes recent events, the stock's technical outlook and analyst recommendation can be viewed by using the following link at no cost:
http://bit.ly/-IGXT-AnalystBrief
Copy and paste to browser may be required.
About Small Cap Traders
Once you read our reports written by our team of financial analysts you will understand that we make every effort to provide informative equity research reports for interested parties at no cost.
Our Financial Analysts spend countless hours researching stocks. They include stocks traded in the NYSE, NASDAQ, and OTCBB exchanges. These reports include a straightforward assessment of the company by a financial analyst who has pledged to remain free of influence when writing research reports.
Forward-Looking Disclaimer
This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward- looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.
Compliance Procedure
Content is researched, written and reviewed on a best-effort basis. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. We do not engage in high frequency trading.
A full disclaimer can be found by viewing the full analyst report.
If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at [email protected]. For any urgent concerns or inquiries please contact us at [email protected].
Contact: [email protected]
SOURCE Small Cap Traders
Share this article